A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
Children's Oncology Group
Immunome, Inc.
Ningbo Newbay Technology Development Co., Ltd
ARCAGY/ GINECO GROUP
Cancer Research UK
PTC Therapeutics
Universität Duisburg-Essen
Blokhin's Russian Cancer Research Center
Karyopharm Therapeutics Inc
Roswell Park Cancer Institute
Nanobiotix
Leiden University Medical Center
Peking University People's Hospital
Assistance Publique - Hôpitaux de Paris
Peking University People's Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
University of Roma La Sapienza
European Organisation for Research and Treatment of Cancer - EORTC
Amneal Pharmaceuticals, LLC
Emory University
Novartis
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Pierian Biosciences
Tata Memorial Hospital